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perfusion syndrome.1 Activation of neutrophils during
CPB, their adhesion to endothelial cells, and adhesion-
dependent release of cytotoxic products are largely
responsible for mediating the inflammatory damage.2,3
Experimental interventions that suppress neutrophil
activation, deplete neutrophils, or block their adhesion to
endothelial cells have been shown to reduce the tissue
injury associated with CPB and ischemia-reperfusion.4-7
A number of soluble mediators are known to activate
neutrophils during CPB and ischemia-reperfusion,
including activated complement anaphylatoxins C3a and
C5a,8,9 tumor necrosis factor a , interleukin (IL) 6 and
IL-8, and leukotriene (LT) B4.10-12 The cellular functions
and interactions of leukocytes with the vascular
endothelium are dependent on expression of surface cell
adhesion receptors.2,13 L-selectin, which is constitutively
expressed on nonactivated leukocytes, is responsible for
C ardiopulmonary bypass (CPB) is associated withsystemic inflammation that can lead to generalized
vascular and organ dysfunction described as the post-
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leukocyte rolling and margination and is rapidly shed on
chemotactic stimulation. Subsequent firm adhesion to
activated endothelium is mediated by the upregulation
of the b 2-integrin complex, particularly CD11b/CD18
(Mac-1). Thus downregulation (loss) of L-selectin and
upregulation of CD11b are indicators of neutrophil acti-
vation and likely vascular transmigration. Previous stud-
ies have found an increased b 2-integrin expression on
circulating blood neutrophils during CPB,14-16 but the
extent to which ischemic reperfusion of the heart and
lungs compared with a general CPB-induced inflamma-
tion contributes to the neutrophil activation has not been
specifically studied. Whether L-selectin expression on
neutrophils is also downregulated during human CPB is
controversial because a decrease in expression has been
found in some studies17,18 but not others.15,19,20 It is also
important to assess whether neutrophil responsiveness
to humoral stimulation can be downregulated after CPB
because this may represent a significant in vivo mecha-
nism to limit neutrophil participation in the inflammato-
ry process.
Thus the aims of the present investigation in patients
undergoing elective coronary artery bypass graft
(CABG) were (1) to characterize the profile of activa-
tion and expression of surface adhesion molecules,
CD11b and L-selectin, on circulating neutrophils dur-
ing CPB and after organ reperfusion; (2) to measure
changes in neutrophil responsiveness to ex vivo agonist
stimulation during and after CPB; and (3) to determine
the presence of neutrophil activation along with neu-
trophil sequestration in the heart and lungs after
ischemic reperfusion.
Methods
Reagents. FACS lysis solution and the following
flourophore-labeled monoclonal antibodies were purchased
from Becton Dickinson-Pharmingen (Rutherford, NJ): mouse
isotype (negative control) IgG1 fluorescein isothiocyanate
(FITC)-IgG2a phycoerythrin (PE); combined FITC–anti-
CD45:PE–anti-CD14 leukocyte typing mix; and FITC–anti-
L-selectin and PE-anti CD11b. Complement C5a was gener-
ated by in vitro zymosan activation of fresh human serum
(zymosan 15 mg/mL serum), and C5a serum supernatant was
stored at –70°C until the day of use. LTB4 was purchased
from Sapphire Bioscience (Alexandria, NSW, Australia) and
stored at –20°C.
Subjects. Twenty patients (18 men and 2 women; mean
age, 61 years; age range, 44-84 years) with stable angina and
left ventricular ejection fraction of greater than 40% under-
going elective CABG, including a graft to the left anterior
descending artery, participated in the study. Their clinical
characteristics are summarized in Table I. The profile of neu-
trophil activation and neutrophil sequestration during and
after surgery was studied in an initial series of 12 patients. Ex
vivo neutrophil responsiveness to agonist stimulation during
and after CPB was examined in an additional 8 patients.
None of the patients had a history of chronic inflammatory
disease, and all had stopped taking aspirin for a minimum of
5 days before surgery. All patients gave written informed con-
sent for their participation in this study, which was approved
by the Human Rights Committee of the University of Western
Australia.
Operative technique. The same surgeon (M.N.) per-
formed CABG using standard operative techniques and with
antegrade and retrograde cold cardioplegic solution delivered
through a catheter in the coronary sinus. All patients had an
internal thoracic artery graft to the left anterior descending
coronary artery, and most had multiple grafts (median, 3;
range, 1-5). Oxygenation on bypass was through membrane
diffusion, and no neutrophil filters were used. A bolus of
heparin (3-4 mg/kg) was given after placement of aortic, atri-
al, and coronary sinus catheters, and further heparin was
given during bypass to maintain an activated clotting time of
greater than 300 seconds. The heparin was reversed with pro-
tamine sulfate after removal of lines. The mean aortic cross-
clamp and CPB times are shown in Table I.
Blood sample collections. At various times, 5 mL of blood
was collected from the peripheral circulation (internal jugular
vein), the ascending aorta, the coronary sinus, and the right
and left atria. Blood taken before systemic heparinization was
collected into heparinized tubes (50 U/mL). All other samples
were collected in sterile polypropylene tubes without addi-
tives. Sampling was performed before anesthesia (T0), after
sternotomy and before commencement of CPB (T1), during
bypass just before release of the aortic crossclamp (T2), 5
minutes after removal of the aortic crossclamp (T3), just
before the end of the bypass (mean 17 ± 2 minutes after
removal of crossclamp; T4), and 5 minutes (T5) and 20 min-
utes (T6) after the bypass.
To assess neutrophil activation and sequestration in the left
coronary circulation, aortic and coronary sinus blood was
collected simultaneously before commencement of CPB
(T1), 5 minutes after removal of the crossclamp (T3), just
before the end of the bypass (T4), and at 5 minutes (T5) and
20 minutes (T6) after the bypass. The pulmonary circulation
was similarly assessed by simultaneous sampling from the
right and left atrium before commencement of CPB (T1) and
at 5 minutes (T5) and 20 minutes (T6) after the bypass.
Table I. Characteristics of the study patients (n = 20)
and CABG
Age, y (mean [range]) 61 (44-84)
Sex (M/F) 18/2
Degree of coronary disease (1/2/3-vessel stenosis) 2/3/15
No. of grafts (median [range]) 3 (1-5)
CPB duration, minutes 70 ± 24
Aortic crossclamping (cardiac ischemia) duration, 40 ± 19
minutes
Temperature during CPB 29°C ± 1°C
Continuous variables are expressed as means ± SD.
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Cell counting. Neutrophil counts and hematocrit levels
were determined on a Coulter Cell counter (Department of
Haematology, PathCentre, QEII Medical Centre, Perth). The
standard error for the leukocyte counts is reported by the
manufacturer as less than 0.02 · 109 cells/L (coefficient of
variability, <1.7%/10,000 cells). To correct for the effect of
hemodilution during CPB, the neutrophil counts were stan-
dardized against the baseline (preanesthetic) hematocrit level
by means of the following equation: corrected neutrophil
count = observed neutrophil count · baseline hematocrit/
observed hematocrit of blood sample.
Neutrophil activation by flow cytometry. Neutrophil
adhesion molecule expression was determined by indirect
immunofluorescent staining of whole blood and flow cytom-
etry.21 Duplicate aliquots of whole blood (80 m L) were incu-
bated in the dark at room temperature for 30 minutes, with 10
m L each of saturating concentrations of FITC- and PE-
labeled monoclonal antibodies. In each sample red blood
cells were lysed, and leukocytes were fixed by incubation
with 1.5 mL of FACS Lysing Solution (Becton Dickinson) for
10 minutes in the dark at room temperature. The samples
were then centrifuged (300g for 5 minutes), and the pellet
was washed with phosphate-buffered saline (PBS) containing
0.1% azide and resuspended in 300 m L of 0.5% (vol/vol)
formaldehyde in PBS. The samples were stored at 4°C until
analyzed later on the day of collection.
Neutrophil CD11b and L-selectin expression was measured
on a FACScan flow cytometer (Becton Dickinson). The neu-
trophil population was identified on the basis of its character-
istic forward and side angle light scatter, and exclusion of
lymphocytes and monocytes from this gate was confirmed by
specific CD45 and CD14 staining, with greater than 90%
neutrophils present in all cases. Five thousand events were
acquired for each sample. Binding of the PE-labeled CD11b
and FITC-labeled L-selectin antibodies to neutrophils was
quantitated both as the percentage of neutrophils exhibiting
specific PE or FITC fluorescence and the mean channel fluo-
rescence (MCF) that exceeded nonspecific background fluo-
rescence. The MCF is expressed in arbitrary units trans-
formed to a linear scale from the log10 channel number of
mean fluorescence and is directly proportional to the density
of receptors expressed per cell.
Neutrophil responses to ex vivo stimulation. A second
cohort of 8 patients was studied to determine whether periph-
eral blood neutrophil responsiveness to ex vivo agonist stimu-
lation was altered during and after CPB. For the neutrophil
stimulation assays, central venous blood samples were taken
preoperatively, at 5 minutes after commencement of CPB, at
5 minutes after removal of the aortic crossclamp, and at 24
hours after CPB. Duplicate 80-m L aliquots of whole blood
were incubated with C5a (1:100 and 1:10 dilution of zymosan-
activated serum), LTB4 (10–8 or 10–6 mol/L), or control (PBS)
for 10 minutes at room temperature. The higher agonist con-
centrations were selected on the basis of previous work in our
laboratory that showed that they produced near maximal
expression of neutrophil surface markers in vitro (data not
shown). Each sample was then labeled with PE-labeled
CD11b and FITC-labeled L-selectin monoclonal antibodies for
subsequent FACScan analysis, as detailed above. Neutrophil
responses to agonist stimulation were determined by the change
in MCF of neutrophils expressing CD11b and L-selectin.
Data processing and statistical analysis. Data are
expressed as means ± SEM unless otherwise stated. For mul-
tiple comparisons, repeated-measures analysis of variance
(ANOVA) for matched samples was used, and where a sig-
nificant difference was identified, pairwise comparisons were
made by using the Dunnett’s multiple comparison posttest
(Instat 2 software; GraphPad, San Diego, Calif).
Fig 1. Peripheral blood neutrophil CD11b and L-selectin mean channel fluorescence (means ± SEM) at preoper-
ative baseline (T0), after sternotomy and before start of CPB (T1), before release of aortic crossclamp (T2), 5 min-
utes after removal of aortic crossclamp (T3), immediately before end of bypass (T4), and 5 minutes (T5) and 20
minutes (T6) after bypass (n = 12). There was a significant increase in CD11b expression during bypass (ANOVA,
P = .003) but no change in L-selectin expression (P > .2). *P < .05 versus preoperative study (T0).
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Results
Peripheral neutrophil count. At baseline, the neu-
trophil count in the peripheral blood was 3.3 ± 0.5 ·
109/L. The corrected neutrophil count fell nonsignifi-
cantly during CPB, but after release of the aortic cross-
clamp, there was a progressive increase in the periph-
eral neutrophil count to 10.4 ± 1.5 · 109/L at 20
minutes after CPB (ANOVA, P < .001).
Peripheral blood neutrophil activation. Fig 1
shows MCF of CD11b and L-selectin on neutrophils in
the peripheral circulation before, during, and after CPB
(T0 to T6) in patients undergoing CABG (n = 12). Fig
2 shows representative flow cytometry histograms from
one subject comparing fluorescence intensity for
CD11b and L-selectin on circulating neutrophils preop-
eratively and during CPB. Over 90% of the entire pop-
ulation of neutrophils expressed CD11b at preoperative
baseline, and the percentage did not change throughout
the time course of study. However, after the start of
CPB, there was a progressive upregulation of CD11b
MCF, indicating a significant increase in CD11b
expression per cell, and this peaked after release of the
aortic crossclamp, at which point it was 145% of base-
line level (ANOVA, P = .003; Fig 1). After weaning off
CPB, the CD11b MCF declined to a nonsignificant
level above baseline at 20 minutes after bypass. L-
selectin was also expressed on over 90% of the entire
population of neutrophils at baseline, and we observed
no downregulation (loss) of L-selectin expression either
in the percentage positive cells or MCF throughout the
course of the study (ANOVA, P > .2; Figs 1 and 2).
Neutrophil responsiveness to ex vivo agonist stim-
ulation. Fig 3 shows the basal and ex vivo stimulated
MCF of CD11b and L-selectin on peripheral blood neu-
trophils sampled at baseline, at 5 minutes after the
onset of CPB, at 5 minutes after release of the aortic
crossclamp, and at 24 hours after CABG (n = 8).
Neutrophil responses to the high-agonist concentra-
tions of C5a (1:10 dilution of activated serum) and
LTB4 (10–6 mol/L) are shown. Neutrophil responses to
C5a (1:100 dilution) and LTB4 (10–8) were generally
small (data not shown). As in the initial series, we
found that the basal level of neutrophil CD11b MCF
increased during CPB, peaking after release of the aor-
Fig 2. Flow cytometry histograms from one subject showing the fluorescence intensity on peripheral blood neu-
trophils preoperatively (solid line) and during CPB (broken line) when labeled for CD11b (top) and L-selectin
(bottom). Note the increased fluorescence intensity of CD11b but the lack of change in fluorescence intensity of
L-selectin on neutrophils sampled during CPB.
Fig 3. Bar graphs showing the basal and ex vivo stimulated
mean channel fluorescence of CD11b (A) and L-selectin (B)
on peripheral blood neutrophils sampled preoperatively
(Preop), at 5 minutes after the onset of CPB (CPB 5 min), at
5 minutes after release of aortic crossclamp (Clamp Off), and
at 24 hours postoperatively (24hr Postop) (n = 8). Neutrophil
agonists were complement C5a (1:10 dilution of activated
serum) and LTB4 (10–6 mol/L). Values are expressed as
means ± SEM. *P < .01 and †P < .001 stimulated versus
basal mean fluorescence expression of CD11b or L-selectin.
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tic crossclamp to 161% of baseline level (ANOVA, P <
.001) but with no change in L-selectin expression. The
CD11b and L-selectin MCF was not significantly dif-
ferent from the baseline level at 24 hours after CPB. At
baseline, ex vivo stimulation by C5a and LTB4
increased neutrophil CD11b MCF expression by more
than 3-fold (both P < .001). There was still a significant
response to ex vivo agonist stimulation by neutrophils
sampled during CPB, although there was a loss of
response by neutrophils sampled 24 hours after CPB
(Fig 3, A). A similar finding was observed with respect
to L-selectin, where neutrophils sampled at baseline
and during CPB responded to ex vivo agonist stimula-
tion by a downregulation of L-selectin MCF (P < .001),
but neutrophils sampled at 24 hours after the operation
failed to respond to stimulation (Fig 3, B).
Neutrophil activation in coronary and pulmonary
circulation. No significant changes in neutrophil
CD11b or L-selectin expression, either percentage of
positive cells or MCF, occurred on single pass across
the left coronary circulation after release of the aortic
crossclamp and at 5 and 20 minutes after CPB nor
across the pulmonary circulation at 5 and 20 minutes
after CPB (data not shown). However, comparison of
the neutrophil counts in blood taken across the left
coronary circulation after aortic crossclamp release
demonstrated a 13% reduction in count after single
pass, and this persisted to 20 minutes after patients
were weaned off CPB (ANOVA, P = .002; Fig 4, A).
An 11% single-pass reduction in neutrophil count was
also found across the pulmonary circulation at 20 min-
utes after CPB (ANOVA, P = .02; Fig 4, B).
Discussion
This study was performed to provide a detailed pro-
file of systemic and local neutrophil activation and
adhesion molecule expression, as well as neutrophil
responses to humoral stimulation in human subjects
undergoing elective CABG with CPB. The major find-
ings were that (1) CPB was associated with a differen-
tial activation of adhesion molecules on circulating
neutrophils with increased b 2-integrin (CD11b) but no
significant change in L-selectin expression; (2) neu-
trophil CD11b expression peaked toward the end of
CPB after release of the aortic crossclamp but declined
rapidly after the end of CPB; (3) there was a downreg-
ulation and loss of neutrophil responses to ex vivo ago-
nist stimulation 24 hours after the operation; and (4) a
significant loss of neutrophils, suggesting sequestration
but no local neutrophil activation, could be demonstrat-
ed in the heart and lungs after reperfusion.
Similar to previous studies, we observed an initial
mild neutropenia during CPB but a marked neutrophil
mobilization and leukocytosis after CPB.9,22 Neutro-
phil mobilization after CPB may be a response to the
release of cytokines and inflammatory mediators from
the heart and other organs on reperfusion, as suggested
by previous studies.10-12 However, other factors, such
as activation of complement by protamine administered
at the end of surgery and circulatory rewarming, may
stimulate neutrophil mobilization postoperatively.9,22
Neutrophil activation with expression of surface
adhesion molecules and the subsequent adhesion of
neutrophils to the vascular endothelium appear to be
key events initiating the inflammatory organ dysfunc-
tion after CPB and ischemia-reperfusion.2-6 Among the
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leukocyte adhesion molecules studied so far, the b 2-
integrins appear to be particularly important because
blockade of the CD11/CD18 complex has been shown
to effectively inhibit neutrophil influx and blunt tissue
injury in many inflammatory conditions, including
ischemia-reperfusion,5,6 the period after CPB,6,7 sep-
sis,23 and shock.24 Our finding that CD11b expression
on circulating neutrophils was markedly upregulated
during human CPB is therefore important and also con-
sistent with that reported by other studies.14-16 In our 2
series of patients undergoing CABG, we found a con-
sistent profile of neutrophil activation with a progres-
sive upregulation of neutrophil CD11b expression after
the onset of CPB, which peaked after the release of the
aortic crossclamp. The early upregulation of CD11b
expression during CPB is most likely related to com-
plement activation from blood-material contact in the
extracorporeal circuit.8,9 However, the late peaking of
neutrophil CD11b expression after aortic crossclamp
release suggests an additional activation of neutrophils
related to coronary reperfusion. Our finding is support-
ed by Gu and colleagues,25 who also reported that
release of the aortic crossclamp induced a second peak
of leukocyte complement–receptor type 3 (mac-1)
expression, paralleled by an increase in LTB4 secretion
in the late period of CPB. We found that CD11b
Fig 4. The differential in neutrophil count (n · 107/L) on single pass across the left coronary circulation (A) and
the pulmonary circulation (B) studied in 12 subjects before commencement of CPB (T1), 5 minutes after release
of aortic clamp (T3), just before end of bypass (T4), and 5 minutes (T5) and 20 minutes after bypass (T6). Values
expressed are means ± SEM. There was a significant increase in differential neutrophil count across the left coro-
nary circulation (ANOVA, P = .002), as well as the pulmonary circulation (ANOVA, P = .02), during postbypass
reperfusion. *P < .05 differential neutrophil count at various time points versus baseline (T1).
A
B
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expression on circulating neutrophils declined rapidly
after bypass, but variables such as the length of CPB
and normothermic versus hypothermic cardioplegia
may explain observed differences in the extent of con-
tinuing neutrophil activation postoperatively.14-16 Our
subsequent data also suggest that the early decline of
CD11b expression may be due to a desensitization of
neutrophils to humoral stimulation.
Unlike CD11b, we found no significant activation
(shedding) of L-selectin on circulating neutrophils.
This may appear surprising given that L-selectin is
important in the initial margination of leukocytes from
the normal blood flow, but other studies have also
failed to show activation of L-selectin on neutrophils in
the peripheral circulation during CPB.15,19,20 By con-
trast, Finn and colleagues17 and Moen and colleagues18
reported a significant downregulation of L-selectin on
neutrophils during human CPB, but this was restricted
to a small proportion of cells, unlike CD11b expres-
sion, which was uniformly increased in the entire neu-
trophil population. Thus we may have failed to detect a
change in L-selectin expression on circulating neu-
trophils because it was confined to a small proportion
of activated neutrophils that were then trapped in the
microcirculation. However, a more likely interpretation
is that the generalized inflammation associated with
CPB can upregulate neutrophil b 2-integrins without
involvement of L-selectin.26The fact that most patients
recover uneventfully after cardiac operations despite
the generalized neutrophil activation suggests that
other mechanisms exist in vivo to limit the inflamma-
tory response. Indeed, one of the most interesting
observations in our study was that circulating neu-
trophils appeared to become anergic to ex vivo agonist
stimulation with C5a and LTB4 by 24 hours postopera-
tively. There are also reports that neutrophil responses
to stimulation by complement or IL-8 may be reduced
after CPB.27,28 These results suggest that being able to
pharmacologically downregulate the response by neu-
trophils, for example by use of LTB4 receptor antago-
nists, may be of benefit in patients undergoing CPB.
We found that there was a significant loss of neu-
trophils across the coronary and pulmonary circula-
tions after bypass, suggesting that neutrophils were
being sequestered. Other studies have also suggested
that neutrophil sequestration occurs in the heart during
reperfusion after bypass,29,30 as well as in the lungs,
where it has been correlated with postbypass ventilato-
ry impairment.8,9 Despite the evident neutrophil
sequestration, we were unable to show a differential of
CD11b or L-selectin expression on neutrophils crossing
both vascular beds during reperfusion. This does not
entirely exclude local neutrophil activation because it
would have been difficult to detect a small change in
CD11b expression during a single pass across the vas-
cular bed when it was already highly expressed on the
majority of circulating neutrophils. Nevertheless, the
upregulated CD11b expression on trafficking neu-
trophils is likely to contribute to neutrophil adhesion
and vascular transmigration. The fact that significant
neutrophil disappearance in the heart and lungs was not
found until some 15 to 20 minutes after reperfusion
suggests that there are time-dependent local factors
determining neutrophil adhesion and transmigration.
This may include a progressive recruitment of local
inflammatory responses in the microcirculation after
ischemic reperfusion and expression of counter ligands
for neutrophils on activated endothelial cells. It is also
possible that neutrophils were later trapped by
microvascular plugging.
The clinical implications of our study are uncertain
because we did not correlate the findings with postby-
pass cardiac or ventilatory function in our patients.
However, they were unlikely to have clinically appar-
ent impairment because of good left ventricular func-
tion and short CPB times. Nevertheless, the demonstra-
tion that even in this group of patients there was
evidence of a marked neutrophil activation and subse-
quent neutrophil sequestration in the heart and lungs
suggests a need for further studies in patients with
unstable syndromes, active ischemia, or long CPB
times undergoing CABG. Furthermore, this study
emphasizes the potential of targeting leukocyte
CD11b-CD18 expression, either by preventing its acti-
vation or by its blockade, as a strategy to reduce the
inflammatory organ dysfunction associated with car-
diopulmonary bypass.
We thank the Departments of Haematology and
Anaesthesiology, Sir Charles Gairdner Hospital, for provid-
ing valuable technical assistance.
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